Valuation: Zomedica Corp.

Market Cap 81.01M 72.7M 67.13M 60.88M 114M 7.69B 115M 805M 320M 4.03B 304M 298M 12.79B P/E 2024
-2.5x
P/E 2025 -1.22x
Enterprise Value 29.94M 26.87M 24.81M 22.5M 42.05M 2.84B 42.56M 297M 118M 1.49B 112M 110M 4.73B EV / Sales 2024
1,761,223x
EV / Sales 2025 1,518,510x
Free-Float
97.25%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Zomedica Corp.

1 day-0.20%
1 week+5.32%
Current month+3.12%
1 month+3.14%
3 months-1.71%
6 months-17.03%
Current year-18.92%
1 week 0.08
Extreme 0.076
0.09
1 month 0.07
Extreme 0.07
0.09
Current year 0.07
Extreme 0.07
0.16
1 year 0.07
Extreme 0.0653
0.16
3 years 0.02
Extreme 0.0151
0.23
5 years 0.02
Extreme 0.0151
0.6
10 years 0.02
Extreme 0.0151
2.98
Manager TitleAgeSince
Chief Executive Officer 69 2021-10-31
Director of Finance/CFO - 2025-04-24
Chief Tech/Sci/R&D Officer - 2017-12-31
Director TitleAgeSince
Director/Board Member 65 2016-04-26
Chairman 70 2019-12-01
Director/Board Member 63 2019-08-15
Date Insider Type Main position Quantity % Market Cap. Importance
8/5/26 Free

Responsable ventes & marketing

250,000 0.0255%
8/5/26 Option

General Counsel

250,000 0.0255%
8/5/26 Option

Responsable ventes & marketing

250,000 0.0255%
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%+5.32%+17.69%-45.65% 81.01M
-0.74%-3.01%+10.27%+33.27% 117B
+2.94%+0.96%-0.57%+107.67% 97.42B
+4.76%+3.72%+126.17%+1,041.83% 59.22B
-0.12%+3.23%-5.94%+90.00% 29.03B
+9.98%+12.78%+40.60%+84.25% 26.86B
+0.97%+2.80%+37.78%+89.81% 26.69B
+3.07%+0.38%+32.02%+407.31% 21.1B
+0.95%+2.20%-16.82%-0.93% 20.61B
-0.13%-1.01%-6.23%+31.16% 16.94B
Average +2.09%+0.48%+23.50%+183.87% 41.45B
Weighted average by Cap. +2.05%-1.33%+25.97%+223.00%

Financials

2024 2025
Net sales 27.28 24.49 22.61 20.5 38.32 2.59K 38.79 271.09 107.66 1.36K 102.42 100.23 4.31K 32.03 28.75 26.54 24.07 44.99 3.04K 45.54 318.24 126.39 1.59K 120.23 117.66 5.06K
Net income -46.98M -42.17M -38.93M -35.31M -65.99M -4.46B -66.8M -467M -185M -2.34B -176M -173M -7.42B -81.86M -73.47M -67.84M -61.52M -115M -7.78B -116M -813M -323M -4.08B -307M -301M -12.92B
Net Debt -69.54M -62.41M -57.63M -52.26M -97.67M -6.61B -98.87M -691M -274M -3.46B -261M -255M -10.98B -51.07M -45.84M -42.32M -38.38M -71.73M -4.85B -72.61M -507M -202M -2.54B -192M -188M -8.06B
Projected Income Statement - Annual - Zomedica Corp.
Logo Zomedica Corp.
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice economics. Its Diagnostics segment consists of TRUFORMA, VETGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi Loop and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field therapy.
Employees
141
Date Price Change Volume
26-10-28 US$0.0825 -0.20% 272,357
26-10-27 US$0.0827 -2.37% 902,838
26-10-26 US$0.0847 +2.75% 938,489
26-10-23 US$0.0824 +5.78% 412,391
26-10-22 US$0.0779 -0.55% 567,568

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Zomedica Corp.
  1. Stock Market
  2. Stocks
  3. ZOMDF Stock